← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2025-08-27

Drug application

FDA Application #

ANDA214568

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

LIRAGLUTIDE

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TEVA PHARMS

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2025-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown